Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism
Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism
Recruiting · NCT07328230 · Registry updated 2026-01-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism | adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, vascular disorder | Recruiting | Not applicable | 2026-01-09 | NCT07328230 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing | China | 5 |
| Second Affiliated Hospital of Nanchang University | Nanchang | China | 7 |
| The First Affiliated Hospital of Chengdu Medical College | Chengdu | China | 7 |